Large-cap biopharma is a "key sector to own" right now, according to Credit Suisse — a view we share that is reflected in the composition of our new 10 core-holdings list . At the Club's "Monthly Meeting" on Thursday, we designated Eli Lilly and Johnson & Johnson as core holdings — a classification reserved for companies that are top operators in their industry with strong track records of creating shareholder value, among other characteristics.
A box of the drug trulicity, made by Eli Lilly Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, January 9, 2020.Large-cap biopharma is a "key sector to own" right now, according to Credit Suisse — a view we share that is reflected in the composition of our
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: